Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 50%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is expected to experience a decline in annual NOI from $313 million to $273 million due to the planned sale of NHC properties, but has the potential for long-term growth opportunities and a successful transition to its focus on the SHOP segment. The company also has strong liquidity with $1.4 billion in total liquidity, including a $500 million ATM program, to support future growth endeavors. However, there is a risk of disruption to government reimbursements and potential competition in the assisted living and senior housing market, which may affect the company's ability to achieve its full potential.

Bears say

National Health Investors is facing a negative outlook due to the recent sale of a majority of its skilled nursing facilities, resulting in a decrease in revenue and accretion. This, combined with the company's high exposure to senior housing and lack of diversification, may lead to volatility in earnings and cash flow. Additionally, the company's potential reliance on third-party operators and a potential decline in occupancy rates could further impact its financial performance.

NHI has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 6 analysts, NHI has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.